Treatment Action Group (TAG) today mourns the premature loss of transformative LGBTQ and AIDS activist Urvashi Vaid, formerly executive director of the National Gay and Lesbian Task Force (now the National LGBTQ Task Force) at the height of the U.S. AIDS crisis in the late 1980s and early 1990s, and peerless leader of the LBGTQ movement for many years thereafter.
A group of six leading HIV/AIDS and viral hepatitis advocates today released the following joint statement regarding recent manufacturer action against the 340B Drug Pricing Program:
At the first of these two public hearings TAG submitted the following statement with six reasons why the new international instrument must explicitly acknowledge the right to science as a central guiding framework.
On April 15 TAG presented, "HIV Updates From CROI: The Good, the Bad, and the Long-Acting." This free webinar unpacked the most significant developments in HIV research presented at the Conference on Retroviruses and Opportunistic Infection (CROI), and what they mean for communities affected by HIV.
On March 3, 2022, we presented the first "Talk About It with TAG" webinar. This series addresses the needs of community members by having open discussions with researchers and community experts on issues related to COVID-19 and HIV biomedical research.
The 2022 Community HIV Cure Research Workshop took place virtually this year due to the ongoing COVID-19 pandemic. There were two sessions, the first on Tuesday February 8th and the second on Tuesday March 1st.
TAG’s staff and board of directors are filled with grief at the premature death of Dr. Paul Farmer, who illuminated and changed our world with his combination of passion, intelligence, solidarity with the poor, and determined will for social justice.
Since 2014, Treatment Action Group’s website has featured a regularly updated listing of clinical trials and observational studies related to the scientific effort to develop a cure for HIV infection. Clinical trials typically involve the administration of experimental interventions, whereas observational studies only require blood draws or other sampling.
On February 9, TAG submitted this testimony to the Office of the High Commission for Human Rights (OHCHR) to inform its upcoming report to the Human Rights Council (HRC) on 'human rights in the context of HIV/AIDS' (HRC resolution 47/17).
Engagement of affected communities in research is vital to ensuring that the science is ethical and responsive to community priorities and needs. This module covers the history of community-based HIV research advocacy and outlines principles and best practices for community…